These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 31572431)

  • 21. Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma.
    Wang P; Wu M; Tu Z; Tao C; Hu Q; Li K; Zhu X; Huang K
    Front Oncol; 2020; 10():1119. PubMed ID: 32974125
    [No Abstract]   [Full Text] [Related]  

  • 22. O
    Yu W; Zhang L; Wei Q; Shao A
    Front Oncol; 2019; 9():1547. PubMed ID: 32010632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CpG methylation signature predicts prognosis in breast cancer.
    Du T; Liu B; Wang Z; Wan X; Wu Y
    Breast Cancer Res Treat; 2019 Dec; 178(3):565-572. PubMed ID: 31520283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methylation Profiling Identifies Epigenetic Markers for High-grade Gliomas.
    Waha A; Rodrigues FJ; Waha A; Meyer-Puttlitz B; Cavenee WK; Huang TH; Wiestler OD; Yan PS
    Cancer Genomics Proteomics; 2004; 1(3):209-214. PubMed ID: 31394655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognostic value of DAPK1 hypermethylation in gliomas: A site-specific analysis.
    Li X; Pu J; Liu J; Chen Y; Li Y; Hou P; Shi B; Yang Q
    Pathol Res Pract; 2018 Jul; 214(7):940-948. PubMed ID: 29807777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Establishment of Novel DNA Methylation-Based Prostate Cancer Subtypes and a Risk-Predicting Eight-Gene Signature.
    Zhang E; Shiori F; Mu OY; He J; Ge Y; Wu H; Zhang M; Song Y
    Front Cell Dev Biol; 2021; 9():639615. PubMed ID: 33708770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA methylation data-based molecular subtype classification and prediction in patients with gastric cancer.
    Lian Q; Wang B; Fan L; Sun J; Wang G; Zhang J
    Cancer Cell Int; 2020; 20():349. PubMed ID: 32742196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development.
    Binder H; Willscher E; Loeffler-Wirth H; Hopp L; Jones DTW; Pfister SM; Kreuz M; Gramatzki D; Fortenbacher E; Hentschel B; Tatagiba M; Herrlinger U; Vatter H; Matschke J; Westphal M; Krex D; Schackert G; Tonn JC; Schlegel U; Steiger HJ; Wick W; Weber RG; Weller M; Loeffler M
    Acta Neuropathol Commun; 2019 Apr; 7(1):59. PubMed ID: 31023364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construction of prognostic risk prediction model of oral squamous cell carcinoma based on co-methylated genes.
    Zhu Q; Tian G; Gao J
    Int J Mol Med; 2019 Sep; 44(3):787-796. PubMed ID: 31198983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unveiling new interdependencies between significant DNA methylation sites, gene expression profiles and glioma patients survival.
    Dabrowski MJ; Draminski M; Diamanti K; Stepniak K; Mozolewska MA; Teisseyre P; Koronacki J; Komorowski J; Kaminska B; Wojtas B
    Sci Rep; 2018 Mar; 8(1):4390. PubMed ID: 29535343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Excavation of Molecular Subtypes of Endometrial Cancer Based on DNA Methylation.
    Liu Y; Gu Y; Zhang M; Zeng J; Wang Y; Wang H; Liu X; Liu S; Wang Z; Wang Y; Wang L; Zhang Y
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneity Analysis of Bladder Cancer Based on DNA Methylation Molecular Profiling.
    Wang S; Xu D; Gao B; Yan S; Sun Y; Tang X; Jiao Y; Huang S; Zhang S
    Front Oncol; 2022; 12():915542. PubMed ID: 35747826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concordant association validates MGMT methylation and protein expression as favorable prognostic factors in glioma patients on alkylating chemotherapy (Temozolomide).
    Pandith AA; Qasim I; Zahoor W; Shah P; Bhat AR; Sanadhya D; Shah ZA; Naikoo NA
    Sci Rep; 2018 Apr; 8(1):6704. PubMed ID: 29712977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic relevance of miRNA-155 methylation in anaplastic glioma.
    Schliesser MG; Claus R; Hielscher T; Grimm C; Weichenhan D; Blaes J; Wiestler B; Hau P; Schramm J; Sahm F; Weiß EK; Weiler M; Baer C; Schmidt-Graf F; Schackert G; Westphal M; Hertenstein A; Roth P; Galldiks N; Hartmann C; Pietsch T; Felsberg J; Reifenberger G; Sabel MC; Winkler F; von Deimling A; Meisner C; Vajkoczy P; Platten M; Weller M; Plass C; Wick W
    Oncotarget; 2016 Dec; 7(50):82028-82045. PubMed ID: 27880937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomas.
    Paz MF; Yaya-Tur R; Rojas-Marcos I; Reynes G; Pollan M; Aguirre-Cruz L; García-Lopez JL; Piquer J; Safont MJ; Balaña C; Sanchez-Cespedes M; García-Villanueva M; Arribas L; Esteller M
    Clin Cancer Res; 2004 Aug; 10(15):4933-8. PubMed ID: 15297393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA methylation status defines clinicopathological parameters including survival for patients with clear cell renal cell carcinoma (ccRCC).
    Evelönn EA; Degerman S; Köhn L; Landfors M; Ljungberg B; Roos G
    Tumour Biol; 2016 Aug; 37(8):10219-28. PubMed ID: 26831665
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Deluche E; Bessette B; Durand S; Caire F; Rigau V; Robert S; Chaunavel A; Forestier L; Labrousse F; Jauberteau MO; Durand K; Lalloué F
    Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 30991699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients' survival.
    Fogli A; Chautard E; Vaurs-Barrière C; Pereira B; Müller-Barthélémy M; Court F; Biau J; Pinto AA; Kémény JL; Khalil T; Karayan-Tapon L; Verrelle P; Costa BM; Arnaud P
    Carcinogenesis; 2016 Feb; 37(2):169-176. PubMed ID: 26717998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive Analysis Reveals a 4-Gene Signature in Predicting Response to Temozolomide in Low-Grade Glioma Patients.
    Wang Q; He Z; Chen Y
    Cancer Control; 2019; 26(1):1073274819855118. PubMed ID: 31167546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery.
    Cimino PJ; Zager M; McFerrin L; Wirsching HG; Bolouri H; Hentschel B; von Deimling A; Jones D; Reifenberger G; Weller M; Holland EC
    Acta Neuropathol Commun; 2017 May; 5(1):39. PubMed ID: 28532485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.